- Switzer Report - https://switzerreport.com.au -

It’s virus-v-vaccine. Vaccine’s the favourite!

It’s the virus versus the vaccine for financial markets, and despite the fact that COVID-19 is having a second shot at the UK, Europe and the USA, the vaccine is getting on top, with even copper hitting a two-year high. This is a good sign for those wanting to believe the vaccine will underwrite a global economic recovery next year. It comes as Chinese Purchasing Manager Indexes are at their best levels since 2018 and construction worldwide is on an uptrend.

This is good news for those invested in commodity-based stocks, which do well in the early phase of an economic upswing.

That said, the rising number of coronavirus cases in the US, which saw New York City and Chicago announce fresh restrictions to curb its spread, supported ‘stay-at-home’ stocks in the technology sector again this week. The seven-day infection average is now 165,029, which is 24% higher than last week and is unsettling Wall Street. On Thursday, the Californian Governor, Gavin Newsom, issued a “limited stay-at-home order” on a majority of the state’s residents, requiring non-essential work and gatherings to cease between 10pm and 5am. This isn’t great with Thanksgiving looming on Thursday and is bound to put pressure on these numbers as families and friends travel to celebrate America’s favourite public holiday.

A stock like Zoom Video was up over 6% overnight and is a classic stay-at-home company. But for the month, it’s still down 19%.

That’s a ‘now’ trade for the short-term player. Those investing for the future, basing their purchases on what stocks will do well next year, have to look to the reopening trade companies.

The fact that the Unibail-Rodamco-Westfield stock was the best performer this week on the ASX (up 25.68%) pretty well proves that. So does the strength that has returned to the energy sector, which is up 22% in two weeks on Wall Street.

Like all stock market situations, there are competing forces and the reopening trade is gaining the upper hand. This was reflected in European share markets, which hit their highest levels in more than eight months on Monday, as hopes for an effective coronavirus vaccine were boosted by positive news from Moderna, whose vaccine was shown to be 94.5% effective in preliminary analysis of a large late-stage clinical trial. Even the good news for the Eli Lilly/Remdesivir treatment added more muscle to beat the virus going forward.

And on the post-election front in the US, despite President Trump’s delayed admission of defeat, sentiment was also boosted after advisers to US President-elect, Joe Biden, said they were opposed to a nationwide COVID-19 lockdown. A moderate Democrat President will be well received by Wall Street, if this considered moderation can be sustained. In part it explains why notable US hedge fund manager, Bill Ackman, told the Sohn Hearts & Minds Conference a week ago that investors should be long stocks in 2021.

This comes as JPMorgan has forecasted a negative 1% growth rate in the US for the first quarter of 2021 because of the infection surge and related restrictions. But because of the favourable vaccine news, it expects the US economy “will expand briskly in 2Q and 3Q.” If this is right, then it will be good for corporate profits next year and justifies why the stock market isn’t convulsing on the infections’ spike right now.

I’ve always argued that vaccine news is going to be critically important to how we play stocks and it’s working out that way, so we have to hope that vaccine news doesn’t turn sour. I’d like to see more progress on stimulus in the US but the current political standoff and handover isn’t helping that important issue for stocks.

To the local story this week, and banks continued their bounce back for the best monthly rise this year. The S&P/ASX 200 Index lost 8 points on Friday to close at 6539.2 but it was up 2.1% for the week, and up a whopping 10.3% so far this month!

In case you missed it, CBA put on 9.4% to end at $80, ANZ rose 8.6% to $22.34, Westpac was up 8.6% to $19.91 and the NAB added 7.2% to $22.73.

Fortunately, the improving economic outlook and comments from APRA, which made the belief that bank dividends would progressively improve, helped the banks find friends on the stock market.

It’s generally felt that this better economic outlook, boosted by our great handling of the virus and the likelihood of vaccines in early 2021 (if not earlier) is all good for financials, energy, retail, health and industrial stocks.

Surprise of the week was Crown Resort’s share price, which finished at $9.33, despite a run of shocking news that included a Moody’s downgrade of its credit rating and a forced delay of the opening of its Barangaroo casino because of regulator concerns.

Not surprisingly, given that Wall Street and other global stock markets seemed more focused on a spring reopening trade rather than a stay-at-home Covid winter fear, gold miners had a bad week, as the Bloomberg/AFR table shows.

What I liked

What I didn’t like

Mesoblast deal

For those wondering why Mesoblast was up 12% for the week, it’s because the company has entered an exclusive licence and collaboration agreement with Novartis to commercialise Mesoblast’s remestemcel-L therapy drug.

The week in review:

Our videos of the week:

Top Stocks – how they fared:

The Week Ahead:

Australia
Monday November 23 – IHS/Markit purchasing managers (November)
Tuesday November 24 – CBA weekly credit & debit card spending
Tuesday November 24 – International trade in goods (October)
Tuesday November 24 – Speech from Reserve Bank official
Wednesday November 25 – Construction work done (September quarter)
Thursday November 26 – Detailed labour force (October)
Thursday November 26 – Business investment (September quarter)

Overseas
Monday November 23 – US National activity index (October)
Monday November 23 – ‘Flash’ purchasing managers index (November)
Tuesday November 24 – US House price indexes (September)
Tuesday November 24 – US Richmond manufacturing index (November)
Wednesday November 25 – US Consumer confidence (November)
Wednesday November 25 – US Economic growth (September quarter)
Wednesday November 25 – US Personal income/spending (October)
Wednesday November 25 – US Durable goods orders (October)
Wednesday November 25 – US International goods (October)
Wednesday November 25 – US New home sales (October)
Wednesday November 25 – US Federal Reserve meeting minutes
Thursday November 26 – China Industrial profits (October)
Thursday November 26 – US Thanksgiving

Food for thought:

“The biggest risk of all is not taking one.” – Mellody Hobson

Stocks shorted:

ASIC releases data daily on the major short positions in the market. These are the stocks with the highest proportion of their ordinary shares that have been sold short, which could suggest investors are expecting the price to come down. The table shows how this has changed compared to the week before.

Chart of the week:

In a note from AMP Capital’s Shane Oliver this week explaining why Australian shares will likely outperform next year, he noted that the performance of local shares versus global shares have seen three distinct waves over the past 30 years as seen in the chart below:

Top 5 most clicked:

Recent Switzer Reports:

Important: This content has been prepared without taking account of the objectives, financial situation or needs of any particular individual. It does not constitute formal advice. Consider the appropriateness of the information in regards to your circumstances.